Abstract
Thirty-two patients (22 boys and 10 girls) with a histologically confirmed diagnosis of ependymoma were treated between 1972 and 1999. A total macroscopic resection was achieved in 16 of these patients, whereas 15 resections were classified by the surgeon as subtotal. In 1 patient a ventriculostomy was created as part of a palliative strategy. All children over 3 years old were treated with postoperative radiotherapy. Chemotherapy consisted of procarbazine, ifosfamide, etoposide, methotrexate, cisplatin and cytosine arabinoside. There was 1 perioperative death. Twenty children developed a relapse of disease within 2 months to 13 years and 1 month after the initial therapy. A maximal number of five recurrences were seen in 1 patient. The value of adjuvant chemotherapy on the prognosis of children with ependymoma seems to be limited. With regard to the poor outcome, the advisability of further treatment after multiple recurrences is debatable.
Similar content being viewed by others
Author information
Authors and Affiliations
Additional information
Received: 15 May 2000 Revised: 20 August 2000
Rights and permissions
About this article
Cite this article
Humpl, T., Neuser, H., Brühl, K. et al. Clinical aspects and prognosis of ependymoma in infants and children A single institution experience. Child's Nerv Syst 17, 246–251 (2001). https://doi.org/10.1007/s003810000402
Issue Date:
DOI: https://doi.org/10.1007/s003810000402